RecruitingNCT02659956

Pathological Basis of MRI Signal Changes in Multiple Sclerosis

The Pathological Basis of MRI Signal Changes in Multiple Sclerosis: A Longitudinal In Vivo-to-Postmortem Study


Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment

250 participants

Start Date

Apr 7, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Multiple sclerosis (MS) is a disease that damages the central nervous system (brain and spinal cord). This leads to increased physical disability over time. The disease is lifelong once it begins. Researchers want to learn more about MS s stages and follow them until a person s death. Objective: To understand how the physical and clinical signs of MS relate to its changes over time. Eligibility: Adults age 18 or older with MS or a disease of the brain and spinal cord that may act like MS. Design: Participants will have a medical history and a complete neurological exam. They may have timed tests of neurological function, such as a 25-foot walk and a 9-hole peg test. Participants will have multi-day visits about once a year. Participants will have blood drawn. Participants may have a brain magnetic resonance imaging (MRI) scan. They may also have an MRI of the spinal cord. They may get a contrast agent (dye) injected into a tube in an arm vein. During the MRI, participants will lie on a table that slides in and out of a metal cylinder. Participants will have the thickness of their retina measured using optical coherence tomography. A camera on top of a table uses lasers. Participants will look through a lens and follow instructions. Eye drops may be used to dilate the pupils. Participants will chew on a piece of sterile cotton for 1 minute to collect saliva. Participants agree to have an autopsy at the time of their death and to donate some of their organs to research, such as the brain and spinal cord.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study is examining brain tissue samples donated after death from people who had multiple sclerosis (MS) — a disease where the immune system attacks the protective coating around nerve fibers in the brain and spinal cord — to understand what the bright or dark spots seen on MRI brain scans actually look like under a microscope, helping researchers understand how MS causes damage. **You may be eligible if...** - You have a diagnosis of multiple sclerosis - You have agreed (or your family has agreed on your behalf) to donate brain tissue for research after death (post-mortem donation) - You had MRI brain scans conducted during your lifetime that can be compared with the donated tissue samples - Your tissue sample is of suitable quality for laboratory analysis **You may NOT be eligible if...** - No prior MRI imaging of your brain is available to compare with tissue samples - Consent for tissue donation was not obtained from you or your family - The cause of death or another factor has made your brain tissue unsuitable for laboratory analysis - Your MS diagnosis cannot be confirmed from medical records Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02659956


Related Trials